the study design involved a 20-week , placebo-controlled , double-blind , randomized cross-over trial , using acebutolol , an agent with partial agonist activity that has been shown to be effective in the treatment of hypertension , cardiac arrhythmias , and angina pectoris .
C0000946
acebutolol
C0020538
hypertension